Protalix BioTherapeutics PLX
NYSE PLX
$2.57 -0.07 (-2.65%)
As of: Oct 21, 2026 · 3:59 PM EDT

Protalix BioTherapeutics (PLX) Interest Coverage Ratio (2024 - 2025)

Updated

Protalix BioTherapeutics' (PLX) Interest Coverage Ratio stood at -690.83 in Q1 2025.

Analysis

Protalix BioTherapeutics (PLX) Interest Coverage Ratio (2024 - 2025) Analysis & Trends

On a TTM basis, Protalix BioTherapeutics' Interest Coverage Ratio came in at 6.75 as of Mar 31, 2025; for FY2024, it came in at 3.69, up 12.1% from FY2023.

  • Across earlier years, Interest Coverage Ratio came in at 3.29 in FY2023.
  • Per Business Quant, the preceding three quarters came in at 175.83 (Q4 2024), 15.35 (Q3 2024) and -6.40 (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.41
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 10.28
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 7.27
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 5.22
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -42.08
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Protalix BioTherapeutics 207.16 Mn 55.78 Mn 12.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -690.83
Dec 31, 2024 175.83
Sep 30, 2024 15.35
Jun 30, 2024 -6.40
API Access

Protalix BioTherapeutics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=PLX&period=max&api_key=YOUR_API_KEY